Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Aug 24 | AVTX Avalo Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 9,500 | 0.00 | 9,500 |
13 Aug 24 | AVTX Avalo Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 9.88 | 24,600 | 243.05 k | 24,600 |
5 Jun 24 | TRML Tourmaline Bio | Stock Option Common Stock | Grant | Acquire A | No | No | 13.91 | 10,000 | 139.10 k | 10,000 |
24 Oct 23 | TRML Tourmaline Bio | Common Stock | Buy | Acquire P | No | No | 11.86 | 7,500 | 88.95 k | 45,391 |
23 Oct 23 | TRML Tourmaline Bio | Stock Option Common Stock | Grant | Acquire A | No | No | 9.46 | 10,000 | 94.60 k | 10,000 |
19 Oct 23 | TRML Tourmaline Bio | Common Stock | Grant | Acquire A | No | No | 0 | 37,891 | 0.00 | 37,891 |
19 Oct 23 | TRML Tourmaline Bio | Stock Option Common Stock | Grant | Acquire A | No | No | 0.13 | 37,890 | 4.93 k | 37,890 |